Tuesday, February 16, 1999
Although a clinical trials agreement between representatives of the
managed care industry and NIH establishes a framework for expanding patient access to
experimental therapies, it is far too early to expect insurers to apply the model to
clinical trials conducted by the private sector.
Last week, the American Association of Health Plans agreed to
guidelines designed to encourage